Total IgE in newborns treated prophylactically with conalbumin

Area of Science:

• Pediatrics
• Immunology
• Food Science

Background:

• Conalbumin is utilized as a prophylactic agent in infant nutrition to prevent enteritis.
• As a heterologous protein, conalbumin possesses potential sensitizing properties.
• The immunological impact of conalbumin in infant feeding requires thorough investigation.

Purpose of the Study:

• To assess the potential of conalbumin to induce allergic sensitization in artificially fed infants.
• To evaluate the effect of conalbumin-treated milk on total immunoglobulin E (IgE) levels.

Main Methods:

• A clinical trial involving 15 artificially fed infants.
• Administration of conalbumin-treated milk for a duration of 60 days.
• Quantification of total IgE levels using the radioimmunoassay method.

Main Results:

• Total IgE values in infants receiving conalbumin-treated milk remained within the normal physiological range.
• No significant increase in IgE levels was observed over the 60-day study period.
• The findings suggest a lack of allergic sensitization attributable to conalbumin.

Conclusions:

• Conalbumin administration in artificially fed infants does not appear to induce allergic sensitization.
• The use of conalbumin as a prophylactic treatment is likely safe concerning IgE-mediated immune responses.
• Further research can explore long-term safety and efficacy in infant nutrition.